SCHEMBL6173753

SCHEMBL6173753

CC(C)Cc1cnccc1C(C)C1(C(C)c2ccncc2CC(C)C)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.43

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 17/20 0.43
AR P10275 1/20 0.33
NTRK1 P04629 1/20 0.32
LMNA P02545 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173174 0.92 IGF1R (0.44) IGF1RARNTRK1
SCHEMBL6174958 0.91 IGF1R (0.43) IGF1RARNTRK1
SCHEMBL6173913 0.91 IGF1R (0.43) IGF1RARNTRK1
SCHEMBL6174841 0.87 IGF1R (0.42) IGF1RNTRK1LMNA
SCHEMBL6174921 0.86 IGF1R (0.43) IGF1RAR
SCHEMBL6173549 0.86 IGF1R (0.43) IGF1RAR
SCHEMBL6174310 0.86 IGF1R (0.43) IGF1RAR
SCHEMBL6177840 0.84 IGF1R (0.43) IGF1RAR
SCHEMBL6172519 0.84 IGF1R (0.38) IGF1RARLMNA
SCHEMBL6175469 0.83 IGF1R (0.41) IGF1RAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed